Clinical Trial Update: Β-OHB Supplementation and Brain Health in Older Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a beta-hydroxybutyrate (β-OHB) supplement for brain health in older adults with subjective cognitive decline; the study status is NOT_Y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subjective Cognitive Decline

Drugs mentioned

• Beta-hydroxybutyrate (β-OHB) supplement (beta-hydroxybutyrate)

Snippet

Sponsor: McMaster University | Conditions: Subjective Cognitive Decline | Phase 2 | Status: NOT_YET_RECRUITING